Clonidine in CKD Management

Guideline Recommendations

• The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggest that many CKD patients will require combination therapy to achieve target blood pressure of <120 mmHg systolic, and clonidine could be part of this regimen in selected patients 1, 2
• The American Heart Association (AHA) and American College of Cardiology (ACC) guidelines caution against initiating low-dose clonidine perioperatively to reduce cardiovascular risk, though this recommendation doesn't apply to continuation of chronic therapy 3

Treatment Considerations

• The American College of Cardiology and American Heart Association recommend careful consideration of clonidine in CKD patients, as abrupt discontinuation can lead to norepinephrine surge and resultant rebound hypertension, which could be particularly dangerous in CKD patients 3
• The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines note that ACE inhibitors and ARBs remain the mainstay of hypertension management in CKD patients with albuminuria, but clonidine offers specific advantages in CKD patients who may not tolerate or have contraindications to first-line agents 1, 4, 5